Apart from the fact that the number of true IgM-positive samples in these two studies was also low (18 and 40, respectively), it should be considered that all four false-negative IgM results in our analysis occurred in patients with special conditions (two patients with B cell-depleting therapy and two patients with vaccine breakthrough infections). This evidence concerns the gene CD40LG and infection.